IP Library › Granted Patent US 12,435,319
Granted Patent B2
US 12,435,319 · App. 18/102,841 · Granted Oct 7, 2025

Double tagged Serratia Marcescens nuclease

Inventors: Dapeng Sun (Lexington, MA); Aine Quimby (Newburyport, MA); Zhenyu Zhu (Lynnfield, MA)
Assignee: AbClonal Science, Inc.
C12N9/16C08B37/003C12Y301/30002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,435,319
App. No.
18/102,841
Granted
Oct 7, 2025
Kind
B2
Abstract

Either wild type or mutant Serratia marcescens Nuclease (“SMN”) is engineered to display a C-terminal Chitin Binding Domain (CBD-tag), followed, at the C-terminus side of the CBD-tag, by a poly-histidine tag (His-tag), where the His-tag is preferably a 6-mer and preferably is preceded by a Gly-Ser linker, thereby generating a recombinant SMN protein that retains dual affinity tags (a CBD-tag and a His-tag) at the C-terminus, to make it easily removed from a reaction solution following digestion of nucleic acids in the reaction mixture. It can also be used for binding SMN to a solid support for use in nucleic acid digestion in a sample contacted with the solid support.

Claims (1)

1. A mutant Serratia Marcescens Nuclease having the amino acid sequence of SEQ ID NO: 2 bound to a nickel magnetic bead through the Chitin Binding Domain tag of SEQ ID NO: 2.

Continuity (1)
Related Publication 20240279626A1 · Aug 22, 2024
References Cited (31)
US 10920202B1 · Zhu · 2021 [cited by examiner]
US 10947518B1 · Zhu et al. · 2021 [cited by applicant]
US 11020474B1 · Xiang et al. · 2021 [cited by applicant]
US 20200283825A1 · Zhu et al. · 2020 [cited by applicant]
US 20200291455A1 · Zhu et al. · 2020 [cited by applicant]
US 20200362320A1 · Zhu et al. · 2020 [cited by applicant]
US 20210079365A1 · Zhu et al. · 2021 [cited by applicant]
US 20210087550A1 · Zhu et al. · 2021 [cited by applicant]
US 20210171925A1 · Zhu et al. · 2021 [cited by applicant]
US 20210403537A1 · Xiang et al. · 2021 [cited by applicant]
US 20220064266A1 · Xiang et al. · 2022 [cited by applicant]
US 20220106576A1 · Zhu et al. · 2022 [cited by applicant]
US 20230033390A1 · Xiang · 2023 [cited by applicant]
US 20230094503A1 · Zhu et al. · 2023 [cited by applicant]
US 20230111383A1 · Zhu et al. · 2023 [cited by applicant]
US 20230212550A1 · Zhu et al. · 2023 [cited by applicant]
US 20230257724A1 · Mandell · 2023 [cited by examiner]
US 20230265412A1 · Zhu et al. · 2023 [cited by applicant]
US 20230295707A1 · Zhu et al. · 2023 [cited by applicant]
US 20240052326A1 · Zhu et al. · 2024 [cited by applicant]
US 20240067951A1 · DiCicco et al. · 2024 [cited by applicant]
US 20240124854A1 · Zhu et al. · 2024 [cited by applicant]
US 20240247246A1 · Sun et al. · 2024 [cited by applicant]
US 20240279626A1 · Sun et al. · 2024 [cited by applicant]
US 20240392264A1 · Zhu et al. · 2024 [cited by applicant]
US 20240392267A1 · Zhu et al. · 2024 [cited by applicant]
US 20240392276A1 · Sun et al. · 2024 [cited by applicant]
US 20240392336A1 · Sun et al. · 2024 [cited by applicant]
US 20250051739A1 · Zhu et al. · 2025 [cited by applicant]
US 20250223574A1 · Zhu et al. · 2025 [cited by applicant]
US 20250236860A1 · Sun et al. · 2025 [cited by applicant]